Anti-Survivin CE/IVD antibodies are specialized immunohistochemistry reagents developed for the detection of Survivin (BIRC5), a multifunctional protein belonging to the inhibitor of apoptosis (IAP) family. Survivin plays a dual biological role by regulating chromosome segregation and mitotic progression as a component of the chromosomal passenger complex while simultaneously promoting cell survival through inhibition of apoptotic pathways and modulation of caspase-dependent signaling. Physiological expression is predominantly restricted to embryonic tissues and proliferating cells, whereas overexpression is observed in numerous human malignancies, establishing Survivin as an important prognostic biomarker and adjunct immunohistochemical marker in pediatric oncology.
Biological Significance of Survivin
- Encoded by the BIRC5 gene, Survivin regulates chromosome segregation, spindle assembly, and cytokinesis during mitosis.
- Functions as a key regulator of cell survival by inhibiting apoptosis and promoting resistance to programmed cell death.
- Highly expressed during fetal development but largely absent from most differentiated adult tissues, with limited expression in selected proliferating cell populations.
- Frequently associated with aggressive tumor behavior, increased proliferative activity, therapeutic resistance, and adverse clinical outcomes.
Diagnostic Utility of Survivin in Pediatric Pathology
In pediatric pathology, Survivin immunohistochemistry serves primarily as an adjunct biomarker in the evaluation of embryonal tumors and small round blue cell tumors. Increased expression has been reported in:
- Neuroblastoma
- Ewing sarcoma
- Rhabdomyosarcoma
- Medulloblastoma
- Wilms tumor
- Pediatric malignant peripheral nerve sheath tumors
Survivin expression has also demonstrated prognostic significance in several pediatric malignancies, where increased expression has been associated with advanced disease stage, treatment resistance, unfavorable clinical outcomes, and reduced survival, although the prognostic impact may vary among tumor types.
Key Features of Survivin CE/IVD Antibodies
- Validated for use on formalin-fixed paraffin-embedded (FFPE) tissues.
- Optimized for both automated and manual immunohistochemistry workflows.
- Typically produce nuclear and/or cytoplasmic staining patterns depending on antibody clone, assay conditions, and tumor type.
- Compatible with heat-induced epitope retrieval (HIER) protocols.
- Manufactured under CE/IVD quality standards to support standardized and reproducible diagnostic performance.
